Kissimmee, FLNCT07438405Now EnrollingIRB Ready

Thyroid Eye Disease Clinical Trial in Kissimmee, FL

Access cutting-edge thyroid eye disease treatment through this clinical trial at a research site in Kissimmee. Study-provided care at no cost to qualified participants.

Sponsored by Amgen

Quick Self-Assessment

See if you qualify for this Kissimmee location

Preparing your pre-screening questions…

Expert Care in Kissimmee

Access thyroid eye disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related thyroid eye disease treatment provided free

Apply for This Kissimmee Location

Check if you qualify for this thyroid eye disease clinical trial in Kissimmee, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kissimmee

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kissimmee site if eligible
  4. 4Begin participation

About This Thyroid Eye Disease Study in Kissimmee

The main objective of this trial is to assess the efficacy of AMG 732 in participants with thyroid eye disease (TED) who are defined as primary nonresponders or relapsed during the safety follow-up in the parent trial (NCT06401044).

Sponsor: Amgen

Who Can Participate

Inclusion Criteria

Signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
Age ≥ 18 years at the time of signing informed consent for parent trial.
Moderate-to-severe TED at the time of enrollment in parent trial and does not require immediate surgical ophthalmological intervention and is not planning corrective surgery/irradiation during the rollover trial.
Any worsening in thyroid status should be corrected to maintain euthyroid status for the entire rollover trial.
Participants must use protocol-specified contraception during treatment and for an additional 6 months after the last dose of trial intervention.
Participants with TED who completed Amgen-sponsored clinical trial of AMG 732.

Exclusion Criteria

Prior orbital irradiation or decompression in the study eye.
Prior adult strabismus surgery.
Use of any steroid (intravenous, oral, or injected) and steroid eye drops or other non-steroid immunosuppressive agent, monoclonal antibody except the trial drug in parent trial within a protocol-specified number of months prior to the first injection of study drug.
Glycated hemoglobin (HbA1c) \> 6.5% and/or fasting glucose levels\> 126 mg/dL (\> 7 mmol/L) at screening.
Malignant condition in the past 5 years or major surgery within 8 weeks or plans to have an elective surgery from screening through end of study.
Active liver or kidney disfunction at screening.
Positive test for hepatitis B/C or Human immunodeficiency virus (HIV) serology at screening.
Known hypersensitivity to teprotumumab, AMG 732 or any other monoclonal antibody products.
Participants have had an adverse event that is considered related to AMG 732 which required study drug interruption/discontinuation in the parent study
Donated blood, or had significant blood loss, or received a transfusion of any blood or blood products within 60 days prior to day 1 dosing or received a plasma donation within 7 days prior to day 1 dosing.
Use of any steroid or other non-steroid immunosuppressive agent, monoclonal antibody, within 3 months prior to the first injection of study drug.
History or existing inflammatory bowel disease (ulcerative colitis or Crohn's disease).
Other protocol-defined inclusion/exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kissimmee?

Yes, this clinical trial (NCT07438405) has an active research site in Kissimmee, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thyroid Eye Disease Treatment Options in Kissimmee, FL

If you're searching for thyroid eye disease treatment options in Kissimmee, FL, this clinical trial (NCT07438405) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kissimmee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thyroid eye disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thyroid eye disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Kissimmee, FL

See all ankylosing spondylitis clinical trials recruiting in Kissimmee — not just this study.

Browse Ankylosing Spondylitis Trials in Kissimmee →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Kissimmee?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kissimmee, FL